The Effect of Anemia and Hypoalbuminemia on Six-Months Hospitalization Risk in End Stage Chronic Kidney Disease Patients Undergoing Hemodialysis: A Retrospective Cohort Study

Octavianus Umboh, Emma Syarifih Moies, Stella Palar


Background: Chronic kidney disease (CKD) patients, particularly those who require renal replacement therapy, have a higher risk of hospitalization and mortality compared than the general population. The patients can suffer hypoalbuminemia and anemia due to chronic inflammations, that might affect the risk of hospitalization risk. The aim of this study is to investigate the effect of albumin dan hemoglobin levels on the hospitalization incidence of patients with stage 5 chronic kidney disease who undergo chronic hemodialysis. Methods: This retrospective cohort study enrolled patients aged 18 years and older with end stage kidney disease who underwent regular hemodialysis at the Prof. dr. R. D Kandou Hospital, Manado, Indonesia. Patients with malignancy were excluded. We measured the hemoglobin and albumin baseline level and observed the hospitalization incidence over the next 6 months. We used the Chi Square test with significance level of p-value 0.05, to analyze the association between both anemia and hypoalbuminemia with risk of hospitalization over 6 months of follow up period. Results: We enrolled 202 patients as our participants, most of whom were men (61.8%), with a mean age of 60.21±9.32 years. There were 120 participants (59.4%) being hospitalized during 6-months-follow-up period. The mean level of albumin was 3.29±0.63 g/dl, while the mean hemoglobin level was 9.43±1.75 g/dl. This study found that most of the participants had hypoalbuminemia (62.9%) while 45% had anemia. We found significant associations between hypoalbuminemia and anemia with the risk of hospitalization within 6 months, with p values 0.001 and 0.007, respectively. The relative risk for being hospitalized over 6 months follow up period in patients having anemia was 2.32 (95% CI 1.29-4.17), and for hypoalbuminemia was 2.77 (95% CI 1.54-4.99). Conclusion: Hypoalbuminemia and anemia are associated with increased risk of all causes hospitalization within 6 months in stage 5 chronic kidney disease patients undergoing hemodialysis.


albumin; chronic kidney disease; hemodialysis; hemoglobin; hospitalization


Kidney Disease Improving Global Outcomes (KDIGO). Clinical practice guideline for the evaluation and management of chronic kidney disease. Journal of The International Society of Nephrology. 2013;3(1):5.

Kalantar-Zadeh K, Li PKT. Strategies to prevent kidney disease and its progression. Nat Rev Nephrol. 2020;16(3):129-30.

Kemenkes RI. Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehatan RI. 2018;53(9):1689-99.

Nistala R, Savin V. Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. Am J Physiol Renal Physiol. 2017;312(4):F661-70.

Ruiz-Ortega M, Rayego-Mateos S, Lamas S, et al. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269-88.

Alisa F, Wulandari C. Faktor-faktor yang berhubungan dengan kepatuhan pasien penyakit ginjal kronik (PGK) yang menjalani hemodialisa di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Mercusuar. 2019;2(2).

Watanabe R. Hyperkalemia in chronic kidney disease. Rev Assoc Med Bras. 2020;66:s31-6.

Tangri N, Inker LA, Hiebert B, et al. A dynamic predictive model for progression of CKD. Am J Kid Dis. 2017;69(4):514-20.

Hounkpatin HO, Fraser SDS, Honney R, et al. Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review. BMC Nephrol. 2020;21(1):1-14.

Lim GJ, Liu YL, Low S, et al. Medical costs associated with severity of chronic kidney disease in type 2 diabetes mellitus in Singapore. Ann Acad Med Singap. 2020;49(10):731-41.

Major RW, Cheng MRI, Grant RA, et al. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One. 2018;13(3).

Arif FM, Sumida K, Molnar MZ, et al. Early mortality associated with inpatient versus outpatient hemodialysis initiation in a large cohort of US veterans with incident end-stage renal disease. Nephron. 2017;137(1):15-22.

Li HL, Tai PH, Hwang YT, Lin SW, et al. Causes of hospitalization among end-stage kidney disease cohort before and after hemodialysis. Int J Environ Res Public Health. 2022;19(16):10253.

Chattopadhyay T, Banerjee A, Mondal H. Causes of hospitalization in patients on maintenance hemodialysis with arteriovenous fistula 1in a tertiary care hospital in West Bengal, India. Saudi J Kidney Dis Transpl. 2021;32(5):1418-23.

Palaka E, Grandy S, van Haalen H, et al. The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes-a systematic literature review. Int J Nephrol. 2020;2020:7692376.

Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge. Kidney Int Suppl. 2002;61(Suppl 80):S35–8.

Levin A, Djurdjev O, Duncan J, et al. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant. 2006;21(2):370-7.

Jurkovitz CT, Abramson JL, Vaccarino LV, et al. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2003;14(11):2919-25.

Abramson JL, Jurkovitz CT, Vaccarino V, et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int. 2003;64(2):610-5.

Vida C, Oliva C, Yuste C, et al. Oxidative stress in patients with advanced CKD and renal replacement therapy: the key role of peripheral blood leukocytes. Antioxidants (Basel). 2021;10(7).

Murphy ST, Parfrey PS. The impact of anemia correction on cardiovascular disease in end-stage renal disease. Semin Nephrol. 2000;20(4):350-5.

Antunes A, Eugenia C, Campas F, et al. Hypoalbuminemiaemia seems to be associated with a higher rate of hospitalization in hemodialysis patients. J. Bras. Nefrol. 2016;38(1):70-5.

Danielski M, Ikizler TA, McMonagle E, et al. Linkage of hypoalbuminemiaemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. American Journal of Kidney Diseases. 2003;42(2):286-94.

Belinskaia DA, Voronina PA, Shmurak VI, et al. Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties. Int J Mol Sci. 2021;22(19).

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.